Researchers at Columbia University’s Zuckerman Institute have discovered that the brain has an astonishing ability to regulate the immune system. This study, conducted in mice, revealed that the brain can both detect inflammation and modulate the immune response, either ramping it up or suppressing it as needed. This finding could pave the way for new therapies to treat a range of diseases where the immune system becomes overactive or dysregulated.
The researchers were driven by a fundamental question: to what extent does the brain control the body’s immune responses? The motivation stemmed from earlier work suggesting that the brain and body communicate extensively through a pathway known as the body-brain axis.
Previous studies hinted at this interaction but did not fully explore the mechanisms or the extent of the brain’s involvement in managing the immune system. The team aimed to uncover these connections and understand how the brain monitors and regulates inflammatory responses, an essential function for maintaining health.
“We found all these ways in which the body is informing the brain about the body’s current state,” said co-first author Mengtong Li, a postdoctoral researcher. “We wanted to understand how much farther the brain’s knowledge and control of the body’s biology went.”
To investigate the brain’s role in immune regulation, the scientists conducted experiments on mice. They focused on the caudal nucleus of the solitary tract (cNST), a brainstem region heavily involved in the body-brain communication pathway. The cNST is the primary target of the vagus nerve.
The researchers used a bacterial compound called lipopolysaccharide (LPS) to trigger an immune response in the mice. This compound is known to activate the innate immune system, the body’s first line of defense against pathogens. They then measured the levels of various immune molecules in the mice, both pro-inflammatory and anti-inflammatory.
To understand the role of the cNST, the researchers chemically manipulated its activity. They used advanced techniques to either suppress or activate the cNST neurons in response to the LPS challenge. They also identified specific groups of neurons within the cNST and the vagus nerve that are involved in detecting and controlling inflammation.
The study revealed that the brain, specifically the cNST, significantly influences the body’s inflammatory responses. When the researchers suppressed the activity of the cNST, they observed a runaway inflammatory response: levels of pro-inflammatory molecules skyrocketed, while anti-inflammatory molecules plummeted. Conversely, when they activated the cNST, the inflammatory response was subdued, with pro-inflammatory molecules decreasing significantly and anti-inflammatory molecules increasing dramatically.
“The brain is the center of our thoughts, emotions, memories and feelings,” said Hao Jin, a co-first author of the study published. “Thanks to great advances in circuit tracking and single-cell technology, we now know the brain does far more than that. It is monitoring the function of every system in the body.”
This indicates that the cNST acts like a thermostat for the immune system, helping to maintain a balanced response to inflammation. The researchers also pinpointed specific neurons in the vagus nerve and the cNST that are crucial for detecting and controlling inflammation. These neurons respond to different immune signals, including pro-inflammatory and anti-inflammatory cytokines, which are molecules that signal immune responses.
While these findings are promising, the study has several limitations. Firstly, the research was conducted in mice, and while there are similarities between mouse and human biology, further studies are needed to confirm that the same mechanisms operate in humans. Additionally, the study focused primarily on the innate immune system, which responds quickly to threats but does not have the memory capabilities of the adaptive immune system. How the brain might influence adaptive immunity remains an open question.
Nevertheless, the implications of this study are far-reaching. If similar mechanisms are found in humans, it could revolutionize the way we treat a variety of immune-related diseases. Conditions such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease, which are currently managed but not cured, might benefit from therapies that target the brain’s control over inflammation.
This discovery could also lead to new treatments for acute inflammatory conditions, such as the severe immune reactions seen in some viral infections, including COVID-19. The potential to modulate the immune system through the brain opens up a new realm of possibilities in medical treatment, offering hope for better management and perhaps even cures for chronic and acute inflammatory diseases.
“This new discovery could provide an exciting therapeutic venue to control inflammation and immunity,” said Charles S. Zuker, the study’s senior author, a principal investigator at Columbia’s Zuckerman Institute and a Howard Hughes Medical Institute investigator.
The study, “A body–brain circuit that regulates body inflammatory responses,” was authored by Hao Jin, Mengtong Li, Eric Jeong, Felipe Castro-Martinez, and Charles S. Zuker.